腹膜透析治疗心肾综合征的研究进展
|
摘要
心肾综合征是心脏和肾脏功能障碍并存且相互影响的复杂疾病状态。腹膜透析能够有效缓解心肾综合征患者的容量负荷过重、改善心功能、减少住院日及再住院率、改善生存。本文就国际上关于该病的发病机制及腹膜透析治疗Ⅱ、Ⅳ型心肾综合征的研究进展作一综述。
Cardiorenal syndrome(CRS) is a disease in which heart and kidney dysfunction coexist and interact with each other. Peritoneal dialysis can effectively relieve the volume load of CRS patients, improve cardiac function, reduce hospitalization period and re-hospitalization rate, and increase survival chance. This article reviews the international research progress in the pathogenesis of this disease and the treatment of type Ⅱ and Ⅳ CRS by using peritoneal dialysis.
Cardiorenal syndrome(CRS) is a disease in which heart and kidney dysfunction coexist and interact with each other. Peritoneal dialysis can effectively relieve the volume load of CRS patients, improve cardiac function, reduce hospitalization period and re-hospitalization rate, and increase survival chance. This article reviews the international research progress in the pathogenesis of this disease and the treatment of type Ⅱ and Ⅳ CRS by using peritoneal dialysis.
引文
[1]Ronco C,Mccullough P,Anker SD,et al.Cardio-renal syndromes:report from the consensus conference of the Acute Dialysis Quality Initiative[J].Eur Heart J,2010,31(6):703-711.
[2]Ledoux P.Cardiorenal syndrome[J].Avenir Med,1951,48(8):149-153.
[3]Colombo PC,Ganda A,Lin J,et al.Inflammatory activation:cardiac,renal,and cardio-renal interactions in patients with the cardiorenal syndrome[J].Heart Fail Rev,2012,17(2):177-190.
[4]Remuzzi G,Cattaneo D,Perico N.The aggravating mechanisms of aldosterone on kidney fibrosis[J].J Am Soc Nephrol,2008,19(8):1459-1462.
[5]Angelini A,Castellani C,Virzi GM,et al.The role of congestion in cardiorenal syndrome type 2:New pathophysiological insight into an experimental model of heart failure[J].Cardiorenal Med,2015,6(1):61-72.
[6]Campese VM.Left ventricular function and chronic kidney disease.How soon does start?[J].Nephrol Dial Transplant,2014,29(11):1989-1991.
[7]Pilz S,Marz W,Wellnitz B,et al.Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography[J].Clin Endocrinol Metab,2008,93(10):3927-3935.
[8]Mullens W,Abrahams Z,Francis CS,et al.Importance of venous congetion for worsing of renal function in advanced decompensated heart failure[J].J Am Coll Cardiol,2009,53(7):589-596.
[9]Lambie M,Chess J,Donovan KL,et al.Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival[J].J Am Soc Nephrol,2013,24(12):2071-2080.
[10]Kunin M,Arad M,Dinour D,et al.Peritoneal dialysis in patients with refractory congestive heart failure:potential prognostic factors[J].Blood Purif 2013,35(4):285-294.
[11]Courivaud C,Kazory A,Crepin T,et al.Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics[J].Perit Dial Int,2014,34(1):100-108.
[12]Bertoli SV,Musetti C,Ciurlino D,et al.Peritoneal ultrafiltration in refractory heart failure:a cohort study[J].Perit Dial Int,2014,34(1):64-70.
[13]Qiuyan Shao,Yangyang Xia,Chunming Jiang,et al.Effectiveness and safety of peritoneal dialysis treatment in patients with refractory congestive heart failure due to chronic cardiorenal syndrome[J].Biomed Res Int,2018:6529283.
[14]王来亮,罗群,朱蓓霞,等,腹膜透析对II型心肾综合征的治疗作用[J].现代实用医学,2018,30(4):478.
[15]米侠,张苗,蒋春明,等,腹膜透析在II型心肾综合征患者中的疗效观察[J].东南大学学报(医学版),2018,37(1):121-124.
[16]Kazory A.Fluid overload as a major target in management of cardiorenal syndrome:Implication for the practice of peritoneal dialysis[J].World J Nephrol,2017,6(4):168-175.
[17]Kazory.Peritoneal dialysis for chronic cardiorenal syndrome:Lessons learned from ultrafiltration trials[J].Word J Cardiol,2015 Jul 26,7(7):392-396.
[18]Wang AY,Wang M,Lam CW,et al.Heart failure in a long-term peritoneal dialysis patients:a 4-year prospective analysis[J].Clin J Am Soc Nephrol,2011,6(4):805-812.
[19]包文晗,史春迎,唐雯,等,影响腹膜透析患者早期生存的因素分析[J].中国血液净化,2018,17(5):289-292.
[2]Ledoux P.Cardiorenal syndrome[J].Avenir Med,1951,48(8):149-153.
[3]Colombo PC,Ganda A,Lin J,et al.Inflammatory activation:cardiac,renal,and cardio-renal interactions in patients with the cardiorenal syndrome[J].Heart Fail Rev,2012,17(2):177-190.
[4]Remuzzi G,Cattaneo D,Perico N.The aggravating mechanisms of aldosterone on kidney fibrosis[J].J Am Soc Nephrol,2008,19(8):1459-1462.
[5]Angelini A,Castellani C,Virzi GM,et al.The role of congestion in cardiorenal syndrome type 2:New pathophysiological insight into an experimental model of heart failure[J].Cardiorenal Med,2015,6(1):61-72.
[6]Campese VM.Left ventricular function and chronic kidney disease.How soon does start?[J].Nephrol Dial Transplant,2014,29(11):1989-1991.
[7]Pilz S,Marz W,Wellnitz B,et al.Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography[J].Clin Endocrinol Metab,2008,93(10):3927-3935.
[8]Mullens W,Abrahams Z,Francis CS,et al.Importance of venous congetion for worsing of renal function in advanced decompensated heart failure[J].J Am Coll Cardiol,2009,53(7):589-596.
[9]Lambie M,Chess J,Donovan KL,et al.Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival[J].J Am Soc Nephrol,2013,24(12):2071-2080.
[10]Kunin M,Arad M,Dinour D,et al.Peritoneal dialysis in patients with refractory congestive heart failure:potential prognostic factors[J].Blood Purif 2013,35(4):285-294.
[11]Courivaud C,Kazory A,Crepin T,et al.Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics[J].Perit Dial Int,2014,34(1):100-108.
[12]Bertoli SV,Musetti C,Ciurlino D,et al.Peritoneal ultrafiltration in refractory heart failure:a cohort study[J].Perit Dial Int,2014,34(1):64-70.
[13]Qiuyan Shao,Yangyang Xia,Chunming Jiang,et al.Effectiveness and safety of peritoneal dialysis treatment in patients with refractory congestive heart failure due to chronic cardiorenal syndrome[J].Biomed Res Int,2018:6529283.
[14]王来亮,罗群,朱蓓霞,等,腹膜透析对II型心肾综合征的治疗作用[J].现代实用医学,2018,30(4):478.
[15]米侠,张苗,蒋春明,等,腹膜透析在II型心肾综合征患者中的疗效观察[J].东南大学学报(医学版),2018,37(1):121-124.
[16]Kazory A.Fluid overload as a major target in management of cardiorenal syndrome:Implication for the practice of peritoneal dialysis[J].World J Nephrol,2017,6(4):168-175.
[17]Kazory.Peritoneal dialysis for chronic cardiorenal syndrome:Lessons learned from ultrafiltration trials[J].Word J Cardiol,2015 Jul 26,7(7):392-396.
[18]Wang AY,Wang M,Lam CW,et al.Heart failure in a long-term peritoneal dialysis patients:a 4-year prospective analysis[J].Clin J Am Soc Nephrol,2011,6(4):805-812.
[19]包文晗,史春迎,唐雯,等,影响腹膜透析患者早期生存的因素分析[J].中国血液净化,2018,17(5):289-292.